Matthew Johnston

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Clinical Evaluation

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)
D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)
D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)
D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)
Rita Humeniuk, Kavita Juneja, Shuguang Chen, Scott Ellis, Olena Anoshchenko, Deqing Xiao, Aaron Share, Matthew Johnston, Santosh Davies, Adam DeZure, Joe Llewellyn, Anu Osinusi, Helen Winter, Sandhya Girish, Ramesh Palaparthy, Mark Dresser
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants. Clinical and translational science (2023)